Indication
hs-CRP
2 clinical trials
4 products
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Quarterly and Monthly TOUR006 in Participants With Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive ProteinStatus: Recruiting, Estimated PCD: 2025-05-01
Product
TOUR006Clinical trial
Effect of Inflammasome Inhibitor on High-sensitivity C-reactive Protein in Patients After Percutaneous Coronary InterventionStatus: Completed, Estimated PCD: 2023-02-01
Product
ColchicineProduct
TranilastProduct
Oridonin